Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Total 13F shares
-
22,686,543
-
Share change
-
-1,856,054
-
Total reported value
-
$1,387,496,635
-
Put/Call ratio
-
289%
-
Price per share
-
$61.24
-
Number of holders
-
436
-
Value change
-
-$127,764,585
-
Number of buys
-
143
-
Number of sells
-
290
Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q4 2021
As of 31 Dec 2021 ARK ETF TR - GENOMIC REV ETF (ARKG) had 436 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 22,686,543 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, BANK OF AMERICA CORP /DE/, UBS Group AG, LPL Financial LLC, WELLS FARGO & COMPANY/MN, Eversept Partners, LP, GOLDMAN SACHS GROUP INC, BNP PARIBAS ARBITRAGE, SA, COMMONWEALTH EQUITY SERVICES, LLC, and JANE STREET GROUP, LLC.
This table shows 438 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.